Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yong Hwang
Incidence of and Risk Factors for Thyroid Dysfunction During Peginterferon Α and Ribavirin Treatment in Patients With Chronic Hepatitis C
Korean Journal of Internal Medicine
Internal Medicine
Related publications
Incidence of Thyroid Dysfunction During Interferon Alfa-2b and Ribavirin Therapy in Men With Chronic Hepatitis C
Archives of Internal Medicine
Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C Associated With Thyroid Dysfunction
Acta Hepatologica Japonica
Hepatology
Peginterferon Alfa-2b and Ribavirin Therapy in Kuwaiti Patients With Chronic Hepatitis C Virus Infection
Eastern Mediterranean Health Journal
Medicine
The Combination of Ribavirin and Peginterferon Is Superior to Peginterferon and Placebo for Children and Adolescents With Chronic Hepatitis C
Gastroenterology
Hepatology
Gastroenterology
Side Effects of Combination Therapy of Peginterferon and Ribavirin for Chronic Hepatitis-C
Internal Medicine
Internal Medicine
Medicine
Economic Burden and Complications of Hepatitis C Virus Patients With and Without Peginterferon and Ribavirin Treatment in Turkey
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost Effectiveness of Interferon or Peginterferon With Ribavirin for Histologically Mild Chronic Hepatitis C
Gut
Gastroenterology
Depressive Episode Incidence in Patients With Chronic Hepatitis C Treated With Pegylated Interferon and Ribavirin
Arquivos de Gastroenterologia
Gastroenterology
Optimum Ribavirin Exposure Overcomes Racial Disparity in Efficacy of Peginterferon and Ribavirin Treatment for Hepatitis C Genotype 1
American Journal of Gastroenterology
Hepatology
Gastroenterology